F-18 FDG

( DrugBank: - / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
127	Frontotemporal lobar degeneration	2

127. Frontotemporal lobar degeneration

Clinical trials : 90 / Drugs : 87 - (DrugBank : 30) / Drug target genes : 39 - Drug target pathways : 88

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01623284 (ClinicalTrials.gov)	March 2010	7/6/2012	PiB PET Scanning in Speech and Language Based Dementias	PiB PET Scanning in Speech and Language Based Dementias	PPA;Primary Progressive Aphasia;Aphasia;Non-fluent Aphasia;Semantic Dementia;Apraxia of Speech;Prima ...	Drug: C-11 PiB;Drug: F-18 FDG	Mayo Clinic	NULL	Completed	18 Years	N/A	Both	168	Phase 1	United States
2	NCT00950430 (ClinicalTrials.gov)	April 2008	29/7/2009	Imaging of Brain Amyloid Plaques in the Aging Population	Brain Amyloid Imaging With Pittsburgh Compound B in Normal Aging, Mild Cognitive Impairment, and Dem ...	Alzheimer's Disease;Dementia With Lewy Bodies;Frontotemporal Dementia;Vascular Dementia	Drug: Pittsburgh Compound B (C-11 PiB);Drug: F-18 FDG;Drug: Tau (18-F-AV-1451)	Mayo Clinic	National Institute on Aging (NIA)	Enrolling by invitation	30 Years	100 Years	All	8000	Phase 4	United States

First Previous1Next Last